Join us for an engaging and informative workshop exploring the evolving landscape of haematological malignancies, with a focus on Leukaemia, Lymphoma, and Multiple Myeloma.
Whether you're new to this area or looking to stay ahead of the latest advancements, this session is designed to deliver both foundational knowledge and important updates for cancer nurses.
Hear from leading experts on the most recent developments shaping the future of blood cancer care, including updates on diagnosis, risk stratification, and emerging treatment pathways. We’ll shine a spotlight on CAR-T cell therapy - exploring its mechanism, real-world application, and the expanding eligibility criteria that are opening the door for more patients to benefit from this revolutionary approach.
We have Tony Calogero, Haematologist, presenting on Leukaemia, Clair Scott, Clinical Nurse Consultant from FSH, presenting on CAR-T cell therapy, Helena Furdas, Nurse Practitioner, presenting and updating us on Lymphoma. Also, Narelle Smith, Lead – Clinical and Community Programs with Myeloma Australia, will present on Multiple Myeloma.
Travel Subsidies
The WA SG offers a travel subsidy program to assist rural/regional WA SG members with financial support to attend WA SG education events. Applications for $500 travel subsidy can be submitted after the workshop via our online form here.
The Subsidy will provide assistance towards airfares or accommodation costs to assist the applicant to attend any of the proposed face to face education events annually. The subsidy will be a maximum value of $500 per calendar year.
Eligibility Criteria
Any individual who is a current rural/regional member of the WA SG may apply for the subsidy. Each individual is only eligible to apply once in a calendar year.
The applicant must be both a financial member of CNSA and a member of the WA SG to be eligible.
Application Requirements
Please contact [email protected] should you have any queries.
Clinical Nurse Consultant
Haematologist
Dr Calogero is a dual-trained clinical and laboratory haematologist who consults to Royal Perth Hospital and SJOG Midland Public and Private Hospital.
Following his training at the University of Western Australia he was part of an Alfred Hospital/ Monash University Myeloma research group.
His roles as Clinical Lead of Haematology for the WA Cancer and Palliative Care Network and Director of Haematology for WA Country Health Service reflect his interest in ensuring equity of access to cancer care and provision of haematology/oncology care to rural and remote patients.
Dr Calogero has a broad range of expertise in both malignant and non-malignant haematology, with special clinical interests in multiple Myeloma, myeloproliferative neoplasms and thrombosis/haemostasis.
His academic interests lay particularly in the teaching of undergraduate health professionals, as well as junior doctors.
Nurse Practitioner
Helena graduated from Curtin University in 2009 and began her career in haematology at Royal Perth Hospital in 2010. Since then, she has dedicated herself to the field, transitioning to Sir Charles Gairdner Hospital in 2020 as the Lymphoma Clinical Nurse Consultant. After earning her Master’s degree from Monash University in 2023, Helena has recently advanced to the role of Lymphoma Nurse Practitioner. She is passionate about providing clinical expertise to individuals living with lymphoma and is committed to expanding nursing services in this vital area.
Lead – Clinical and Community Programs
Narelle Smith works as the Specialist Myeloma Nurse for Western Australia and leads the nursing and community programs nationally for Myeloma Australia, where she has spent nearly eight years supporting the myeloma community and their caregivers through education, support and advocacy. Drawing on over 20 years of cancer nursing experience across a variety of fields including clinical care, project management, research, and education both locally and internationally, she is passionate about delivering holistic care and inspiring her peers to do the same. Narelle's work centres on improving outcomes for people with myeloma, promoting awareness, fostering the knowledge and understanding of myeloma in health professionals across the board and equipping patients, carers and families with the tools to advocate for themselves in often challenging circumstances.
Please accept {{cookieConsents}} cookies to view this content